Reports on the action taken by Johnson & Johnson to terminate its clinical trial for Topamax, a weight-loss drug, because of the side effects experienced by participants when given high doses of the drug.Wall Street Journal - Eastern Edition...
Topiramate, the active ingredient in Topamax, is also a main ingredient in the weight-loss drug Qsymia, along with phentermine. The FDA approved Qsymia in 2012. A year earlier, the same drug — then called Qnexa — was rejected by the FDA because of the adverse side effect profile of the...
Unexplained weight loss may not seem a cause for concern, and it's easy to ignore. But this kind of weight loss likely is a clue to an illness that needs to be diagnosed and treated. Your healthcare provider can help find the cause, and treat both the underlying condition and the weigh...
Topamax and Weight Loss Topamax, known generically as topiramate, is a drug that is used to treat certain kinds of seizures, mood disorders and to prevent migraine headaches. It seems to induce weight loss by suppressing your appetite and affecting certain hormones in your body; namely, insulin,...
翻译结果3复制译文编辑译文朗读译文返回顶部 This year called "Qnexa" experimental drug shows it can take approximately 1 year reducing the weight of 10%. This drug is in fact two kinds of drug preparations, namely, weight-loss drugs "Phentermine" and antiepileptic drugs "TOPAMAX" mixture. This ...